scholarly journals Deep learning prediction of mild cognitive impairment conversion to Alzheimer’s disease at 3 years after diagnosis using longitudinal and whole-brain 3D MRI

2021 ◽  
Vol 7 ◽  
pp. e560
Author(s):  
Ethan Ocasio ◽  
Tim Q. Duong

Background While there is no cure for Alzheimer’s disease (AD), early diagnosis and accurate prognosis of AD may enable or encourage lifestyle changes, neurocognitive enrichment, and interventions to slow the rate of cognitive decline. The goal of our study was to develop and evaluate a novel deep learning algorithm to predict mild cognitive impairment (MCI) to AD conversion at three years after diagnosis using longitudinal and whole-brain 3D MRI. Methods This retrospective study consisted of 320 normal cognition (NC), 554 MCI, and 237 AD patients. Longitudinal data include T1-weighted 3D MRI obtained at initial presentation with diagnosis of MCI and at 12-month follow up. Whole-brain 3D MRI volumes were used without a priori segmentation of regional structural volumes or cortical thicknesses. MRIs of the AD and NC cohort were used to train a deep learning classification model to obtain weights to be applied via transfer learning for prediction of MCI patient conversion to AD at three years post-diagnosis. Two (zero-shot and fine tuning) transfer learning methods were evaluated. Three different convolutional neural network (CNN) architectures (sequential, residual bottleneck, and wide residual) were compared. Data were split into 75% and 25% for training and testing, respectively, with 4-fold cross validation. Prediction accuracy was evaluated using balanced accuracy. Heatmaps were generated. Results The sequential convolutional approach yielded slightly better performance than the residual-based architecture, the zero-shot transfer learning approach yielded better performance than fine tuning, and CNN using longitudinal data performed better than CNN using a single timepoint MRI in predicting MCI conversion to AD. The best CNN model for predicting MCI conversion to AD at three years after diagnosis yielded a balanced accuracy of 0.793. Heatmaps of the prediction model showed regions most relevant to the network including the lateral ventricles, periventricular white matter and cortical gray matter. Conclusions This is the first convolutional neural network model using longitudinal and whole-brain 3D MRIs without extracting regional brain volumes or cortical thicknesses to predict future MCI to AD conversion at 3 years after diagnosis. This approach could lead to early prediction of patients who are likely to progress to AD and thus may lead to better management of the disease.

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Kanghan Oh ◽  
Young-Chul Chung ◽  
Ko Woon Kim ◽  
Woo-Sung Kim ◽  
Il-Seok Oh

AbstractRecently, deep-learning-based approaches have been proposed for the classification of neuroimaging data related to Alzheimer’s disease (AD), and significant progress has been made. However, end-to-end learning that is capable of maximizing the impact of deep learning has yet to receive much attention due to the endemic challenge of neuroimaging caused by the scarcity of data. Thus, this study presents an approach meant to encourage the end-to-end learning of a volumetric convolutional neural network (CNN) model for four binary classification tasks (AD vs. normal control (NC), progressive mild cognitive impairment (pMCI) vs. NC, stable mild cognitive impairment (sMCI) vs. NC and pMCI vs. sMCI) based on magnetic resonance imaging (MRI) and visualizes its outcomes in terms of the decision of the CNNs without any human intervention. In the proposed approach, we use convolutional autoencoder (CAE)-based unsupervised learning for the AD vs. NC classification task, and supervised transfer learning is applied to solve the pMCI vs. sMCI classification task. To detect the most important biomarkers related to AD and pMCI, a gradient-based visualization method that approximates the spatial influence of the CNN model’s decision was applied. To validate the contributions of this study, we conducted experiments on the ADNI database, and the results demonstrated that the proposed approach achieved the accuracies of 86.60% and 73.95% for the AD and pMCI classification tasks respectively, outperforming other network models. In the visualization results, the temporal and parietal lobes were identified as key regions for classification.


2019 ◽  
Author(s):  
Jinhyeong Bae ◽  
Jane Stocks ◽  
Ashley Heywood ◽  
Youngmoon Jung ◽  
Lisanne Jenkins ◽  
...  

AbstractDementia of Alzheimer’s Type (DAT) is associated with a devastating and irreversible cognitive decline. As a pharmacological intervention has not yet been developed to reverse disease progression, preventive medicine will play a crucial role for patient care and treatment planning. However, predicting which patients will progress to DAT is difficult as patients with Mild Cognitive Impairment (MCI) could either convert to DAT (MCI-C) or not (MCI-NC). In this paper, we develop a deep learning model to address the heterogeneous nature of DAT development. Structural magnetic resonance imaging was utilized as a single biomarker, and a three-dimensional convolutional neural network (3D-CNN) was developed. The 3D-CNN was trained using transfer learning from the classification of Normal Control and DAT scans at the source task. This was applied to the target task of classifying MCI-C and MCI-NC scans. The model results in 82.4% classification accuracy, which outperforms current models in the field. Furthermore, by implementing an occlusion map approach, we visualize key brain regions that significantly contribute to the prediction of MCI-C and MCI-NC. Results show the hippocampus, amygdala, cerebellum, and pons regions as significant to prediction, which are consistent with current understanding of disease. Finally, the model’s prediction value is significantly correlated with rates of change in clinical assessment scores, indicating the model is able to predict an individual patient’s future cognitive decline. This information, in conjunction with the identified anatomical features, will aid in building a personalized therapeutic strategy for individuals with MCI. This model could also be useful for selection of participants for clinical trials.


2021 ◽  
Vol ahead-of-print (ahead-of-print) ◽  
Author(s):  
Emre Kiyak ◽  
Gulay Unal

Purpose The paper aims to address the tracking algorithm based on deep learning and four deep learning tracking models developed. They compared with each other to prevent collision and to obtain target tracking in autonomous aircraft. Design/methodology/approach First, to follow the visual target, the detection methods were used and then the tracking methods were examined. Here, four models (deep convolutional neural networks (DCNN), deep convolutional neural networks with fine-tuning (DCNNFN), transfer learning with deep convolutional neural network (TLDCNN) and fine-tuning deep convolutional neural network with transfer learning (FNDCNNTL)) were developed. Findings The training time of DCNN took 9 min 33 s, while the accuracy percentage was calculated as 84%. In DCNNFN, the training time of the network was calculated as 4 min 26 s and the accuracy percentage was 91%. The training of TLDCNN) took 34 min and 49 s and the accuracy percentage was calculated as 95%. With FNDCNNTL, the training time of the network was calculated as 34 min 33 s and the accuracy percentage was nearly 100%. Originality/value Compared to the results in the literature ranging from 89.4% to 95.6%, using FNDCNNTL, better results were found in the paper.


2022 ◽  
Vol 23 (1) ◽  
Author(s):  
Tulika Kakati ◽  
Dhruba K. Bhattacharyya ◽  
Jugal K. Kalita ◽  
Trina M. Norden-Krichmar

Abstract Background A limitation of traditional differential expression analysis on small datasets involves the possibility of false positives and false negatives due to sample variation. Considering the recent advances in deep learning (DL) based models, we wanted to expand the state-of-the-art in disease biomarker prediction from RNA-seq data using DL. However, application of DL to RNA-seq data is challenging due to absence of appropriate labels and smaller sample size as compared to number of genes. Deep learning coupled with transfer learning can improve prediction performance on novel data by incorporating patterns learned from other related data. With the emergence of new disease datasets, biomarker prediction would be facilitated by having a generalized model that can transfer the knowledge of trained feature maps to the new dataset. To the best of our knowledge, there is no Convolutional Neural Network (CNN)-based model coupled with transfer learning to predict the significant upregulating (UR) and downregulating (DR) genes from both trained and untrained datasets. Results We implemented a CNN model, DEGnext, to predict UR and DR genes from gene expression data obtained from The Cancer Genome Atlas database. DEGnext uses biologically validated data along with logarithmic fold change values to classify differentially expressed genes (DEGs) as UR and DR genes. We applied transfer learning to our model to leverage the knowledge of trained feature maps to untrained cancer datasets. DEGnext’s results were competitive (ROC scores between 88 and 99$$\%$$ % ) with those of five traditional machine learning methods: Decision Tree, K-Nearest Neighbors, Random Forest, Support Vector Machine, and XGBoost. DEGnext was robust and effective in terms of transferring learned feature maps to facilitate classification of unseen datasets. Additionally, we validated that the predicted DEGs from DEGnext were mapped to significant Gene Ontology terms and pathways related to cancer. Conclusions DEGnext can classify DEGs into UR and DR genes from RNA-seq cancer datasets with high performance. This type of analysis, using biologically relevant fine-tuning data, may aid in the exploration of potential biomarkers and can be adapted for other disease datasets.


2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Young-Gon Kim ◽  
Sungchul Kim ◽  
Cristina Eunbee Cho ◽  
In Hye Song ◽  
Hee Jin Lee ◽  
...  

AbstractFast and accurate confirmation of metastasis on the frozen tissue section of intraoperative sentinel lymph node biopsy is an essential tool for critical surgical decisions. However, accurate diagnosis by pathologists is difficult within the time limitations. Training a robust and accurate deep learning model is also difficult owing to the limited number of frozen datasets with high quality labels. To overcome these issues, we validated the effectiveness of transfer learning from CAMELYON16 to improve performance of the convolutional neural network (CNN)-based classification model on our frozen dataset (N = 297) from Asan Medical Center (AMC). Among the 297 whole slide images (WSIs), 157 and 40 WSIs were used to train deep learning models with different dataset ratios at 2, 4, 8, 20, 40, and 100%. The remaining, i.e., 100 WSIs, were used to validate model performance in terms of patch- and slide-level classification. An additional 228 WSIs from Seoul National University Bundang Hospital (SNUBH) were used as an external validation. Three initial weights, i.e., scratch-based (random initialization), ImageNet-based, and CAMELYON16-based models were used to validate their effectiveness in external validation. In the patch-level classification results on the AMC dataset, CAMELYON16-based models trained with a small dataset (up to 40%, i.e., 62 WSIs) showed a significantly higher area under the curve (AUC) of 0.929 than those of the scratch- and ImageNet-based models at 0.897 and 0.919, respectively, while CAMELYON16-based and ImageNet-based models trained with 100% of the training dataset showed comparable AUCs at 0.944 and 0.943, respectively. For the external validation, CAMELYON16-based models showed higher AUCs than those of the scratch- and ImageNet-based models. Model performance for slide feasibility of the transfer learning to enhance model performance was validated in the case of frozen section datasets with limited numbers.


2021 ◽  
pp. 1-10
Author(s):  
Gayatri Pattnaik ◽  
Vimal K. Shrivastava ◽  
K. Parvathi

Pests are major threat to economic growth of a country. Application of pesticide is the easiest way to control the pest infection. However, excessive utilization of pesticide is hazardous to environment. The recent advances in deep learning have paved the way for early detection and improved classification of pest in tomato plants which will benefit the farmers. This paper presents a comprehensive analysis of 11 state-of-the-art deep convolutional neural network (CNN) models with three configurations: transfers learning, fine-tuning and scratch learning. The training in transfer learning and fine tuning initiates from pre-trained weights whereas random weights are used in case of scratch learning. In addition, the concept of data augmentation has been explored to improve the performance. Our dataset consists of 859 tomato pest images from 10 categories. The results demonstrate that the highest classification accuracy of 94.87% has been achieved in the transfer learning approach by DenseNet201 model with data augmentation.


Sign in / Sign up

Export Citation Format

Share Document